While SPA17, lymph node metastasis, tumor size, PR status, Ki-67 status, molecular subtyping, endocrine-therapy and radiotherapy were associated with disease-free survival (Tables 2, 3). This evidence concerns the gene SPA17 and metastatic malignant neoplasm in the lymph nodes.